NHS Inquiry Finds WellBN Harmed 78 Children With Gender Drugs, Halting New Prescriptions
Updated
Updated · BBC.com · Jun 11
NHS Inquiry Finds WellBN Harmed 78 Children With Gender Drugs, Halting New Prescriptions
3 articles · Updated · BBC.com · Jun 11
Summary
78 under-18 patients at Brighton GP practice WellBN were potentially harmed after clinicians prescribed puberty blockers and cross-sex hormones between 2023 and late 2025 without proper checks, an NHS safety inquiry found.
More than 20 children received medication without a face-to-face appointment, and investigators said none of the clinicians reviewed were competent to start children on gender drugs; blood tests and specialist input were often missing.
44 children aged 16 and under were given puberty-suppressing drugs, including 12 under 13, while 51 aged 16 and under received cross-sex hormones, including four under 13; 53 of the 78 cases showed possible neurodevelopmental issues.
NHS England ordered WellBN to stop issuing new prescriptions to children, referred current and former clinicians to regulators, and suspended one doctor from NHS GP work pending further investigation.
The case grew out of family complaints and long waits for specialist gender services; it lands after the Cass review prompted tighter UK rules, including a 2024 puberty-blocker ban outside trials and a March 2026 pause on new prescriptions for 16- and 17-year-olds.
As the UK bans private gender care, what happens to youths who say these treatments are their only lifeline?
A GP bypassed NHS rules to treat teens. Was this a dangerous failure or a symptom of a broken system?
Is the gender care debate ignoring a much wider youth mental health and neurodiversity crisis?
NHS Inquiry Finds 78 Children Potentially Harmed at WellBN: Fallout, Family Impact, and Policy Overhaul in Gender Care
Overview
The NHS inquiry into the WellBN GP practice, released in June 2026, followed years of advocacy from community groups and parents who raised serious ethical and medical concerns about gender-related care at the Brighton WellBN trans health hub. Parents, especially from PSHE Brighton, consistently warned about harm to children and families, but their concerns were often dismissed. The investigation found that stress from WellBN’s practices had deeply affected family relationships, sometimes causing estrangement. PSHE Brighton welcomed the inquiry and offered to provide evidence, highlighting the urgent need for better oversight and support for affected families.